(Q48417159)

11 February 2018

title

Tracking atrophy progression in familial Alzheimer's disease: a serial MRI study. (English)

1 reference

11 February 2018

magnetic resonance imaging

main subject

Alzheimer's disease

0 references

0 references

author

Jonathan Bartlett

3

1 reference

11 February 2018

Nick C. Fox

7

1 reference

11 February 2018

Alison K. Godbolt

Alison Godbolt

4

0 references

Josephine Barnes

Josephine Barnes

2

0 references

Martin Rossor

Martin N Rossor

6

0 references

Tracey Pepple

5

Tracey Pepple

1 reference

11 February 2018

Basil H Ridha

1

Basil H Ridha

1 reference

11 February 2018

publication date

1 October 2006

1 reference

11 February 2018

published in

Lancet Neurology

1 reference

11 February 2018

volume

5

1 reference

11 February 2018

page(s)

828-834

1 reference

11 February 2018

issue

10

1 reference

11 February 2018

Staging of Alzheimer-related cortical destruction

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970550-6

7 January 2021

Mild cognitive impairment represents early-stage Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970550-6

7 January 2021

The histological validation of post mortem magnetic resonance imaging-determined hippocampal volume in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970550-6

7 January 2021

Hippocampal volume as an index of Alzheimer neuropathology: findings from the Nun Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970550-6

7 January 2021

MR‐based hippocampal volumetry in the diagnosis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970550-6

7 January 2021

Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970550-6

7 January 2021

Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970550-6

7 January 2021

Amyloid, the presenilins and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970550-6

7 January 2021

Presymptomatic cognitive deficits in individuals at risk of familial Alzheimer's disease. A longitudinal prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970550-6

7 January 2021

Assessing the onset of structural change in familial Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970550-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970550-6

1 reference

7 January 2021

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970550-6

7 January 2021

Mild cognitive impairment: clinical characterization and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970550-6

7 January 2021

Interactive algorithms for the segmentation and quantitation of 3-D MRI brain scans.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970550-6

7 January 2021

The boundary shift integral: an accurate and robust measure of cerebral volume changes from registered repeat MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970550-6

7 January 2021

A probabilistic atlas of the human brain: theory and rationale for its development. The International Consortium for Brain Mapping (ICBM).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970550-6

7 January 2021

Differentiating AD from aging using semiautomated measurement of hippocampal atrophy rates.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970550-6

7 January 2021

Small sample inference for fixed effects from restricted maximum likelihood.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970550-6

7 January 2021

The analysis of repeated 'direct' measures of change illustrated with an application in longitudinal imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970550-6

7 January 2021

A longitudinal study of brain volume changes in normal aging using serial registered magnetic resonance imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970550-6

7 January 2021

Rates of hippocampal atrophy correlate with change in clinical status in aging and AD.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970550-6

7 January 2021

Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970550-6

7 January 2021

Regional brain atrophy rate predicts future cognitive decline: 6-year longitudinal MR imaging study of normal aging

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970550-6

7 January 2021

Hippocampal disconnection contributes to memory dysfunction in individuals at risk for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970550-6

7 January 2021

Imaging cerebral atrophy: normal ageing to Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970550-6

7 January 2021

10.1016/S1474-4422(06)70550-6

Identifiers

DOI

1 reference

11 February 2018

PubMed ID

16987729

1 reference

11 February 2018